Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer

[1]  Xiaohe Chu,et al.  Improved paclitaxel delivery with PEG-b-PLA/zein nanoparticles prepared via flash nanoprecipitation. , 2022, International journal of biological macromolecules.

[2]  X. Wang,et al.  Drug-loaded PEG-PLGA nanoparticles for cancer treatment , 2022, Frontiers in Pharmacology.

[3]  Paweena Dana,et al.  Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy , 2022, Nanomaterials.

[4]  Jiao Feng,et al.  Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. , 2022, Advanced drug delivery reviews.

[5]  Yi‐Cheun Yeh,et al.  Progress in the drug encapsulation of poly(lactic-co-glycolic acid) and folate-decorated poly(ethylene glycol)-poly(lactic-co-glycolic acid) conjugates for selective cancer treatment. , 2022, Journal of materials chemistry. B.

[6]  B. Choudhary,et al.  ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model , 2022, Frontiers in Oncology.

[7]  Yejiao Shi,et al.  Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes , 2022, Chinese Chemical Letters.

[8]  A. Ivanova,et al.  A phase I evaluation of the effect of curcumin on dose‐limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors , 2022, Clinical and translational science.

[9]  Yanhong Wang,et al.  Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells , 2021, Frontiers in Oncology.

[10]  María de Jesús Ibarra-Sánchez,et al.  Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells , 2021, Oncology Letters.

[11]  Yuzhu Hu,et al.  Co-delivery of doxorubicin and curcumin via cRGD-peptide modified MPEG-PLA self-assembly nanomicelles for lung cancer therapy , 2021, Chinese Chemical Letters.

[12]  J. Zhang,et al.  Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism , 2021, Clinical and Translational Oncology.

[13]  H. Abrahamse,et al.  Targeted Photodynamic Therapy Using Alloyed Nanoparticle-Conjugated 5-Aminolevulinic Acid for Breast Cancer , 2021, Pharmaceutics.

[14]  E. Rutgers,et al.  Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  F. Ungaro,et al.  Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells. , 2021, Nanoscale.

[16]  Shaoling Lin,et al.  Preparation and photodynamic bactericidal effects of curcumin-β-cyclodextrin complex. , 2021, Food chemistry.

[17]  J. Espín,et al.  Disposition of Dietary Polyphenols in Breast Cancer Patients' Tumors, and their Associated Anticancer Activity: the Particular Case of Curcumin. , 2021, Molecular nutrition & food research.

[18]  C. Denkert,et al.  Breast cancer , 2021, The Lancet.

[19]  Qubo Zhu,et al.  PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application , 2021, Drug delivery.

[20]  B. Nowack,et al.  Probabilistic modelling of nanobiomaterial release from medical applications into the environment. , 2020, Environment international.

[21]  Biqiong Wang,et al.  Co-delivery of Paclitaxel and Curcumin by Biodegradable Polymeric Nanoparticles for Breast Cancer Chemotherapy. , 2020, International journal of pharmaceutics.

[22]  L. Farahmand,et al.  Breast cancer: Biology, biomarkers, and treatments. , 2020, International immunopharmacology.

[23]  P. Poma,et al.  Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View , 2020, International journal of molecular sciences.

[24]  J. Arnhold,et al.  Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[25]  Hanan M Elnahas,et al.  Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles , 2020, Drug delivery.

[26]  Yurun Shen,et al.  Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy , 2020, Journal of liposome research.

[27]  P. Kubatka,et al.  Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer , 2019, Biomolecules.

[28]  A. Giordano,et al.  Curcumin and Cancer , 2019, Nutrients.

[29]  Hong Yang,et al.  Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer , 2019, Nanoscale research letters.

[30]  Huile Gao,et al.  Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis. , 2019, Biomaterials.

[31]  L. Howells,et al.  Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial , 2019, The Journal of nutrition.

[32]  D. Mondhe,et al.  Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. , 2019, Materials science & engineering. C, Materials for biological applications.

[33]  Ying Zheng,et al.  Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles , 2018, Acta pharmaceutica Sinica. B.

[34]  Qingdi Zhu,et al.  Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. , 2018, Materials science & engineering. C, Materials for biological applications.

[35]  K. M. Au,et al.  Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. , 2018, Biomaterials.

[36]  Wei-Wei Tang,et al.  An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. , 2018, Bioscience trends.

[37]  Youxin Li,et al.  Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo , 2018, International journal of nanomedicine.

[38]  R. Kumar,et al.  Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer , 2018, International journal of nanomedicine.

[39]  Qiang Zhang,et al.  Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft , 2018, Drug delivery.

[40]  M. Akram,et al.  Awareness and current knowledge of breast cancer , 2017, Biological Research.

[41]  Y. Luan,et al.  Co-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancer. , 2017, Colloids and surfaces. B, Biointerfaces.

[42]  Shashank K Singh,et al.  Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine. , 2016, International journal of biological macromolecules.

[43]  M. Coumar,et al.  BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway--A comparative study with curcumin. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[44]  X. Sui,et al.  Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery , 2012, International journal of nanomedicine.

[45]  Francis S. Romanski,et al.  Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  R. J. Anto,et al.  Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. , 2011, The international journal of biochemistry & cell biology.

[47]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[48]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[49]  H. Pehamberger,et al.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. , 2004, The Journal of clinical investigation.